Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Modecate Concentrate 100mg/1ml inj ampoules (Sanofi)
0402020L0BBAGAF
|
Modecate | Fluphenazine decanoate | Central Nervous System | 5 |
|
Modecate 25mg/1ml solution for injection ampoules (Sanofi)
0402020L0BBABAC
|
Modecate | Fluphenazine decanoate | Central Nervous System | 3 |
|
Modecate 12.5mg/0.5ml solution for injection ampoules
0402020L0BBAAAA
|
Modecate | Fluphenazine decanoate | Central Nervous System | No data available |
|
Modecate 250mg/10ml solution for injection vials
0402020L0BBADAE
|
Modecate | Fluphenazine decanoate | Central Nervous System | No data available |
|
Modecate 25mg/1ml inj ampoules (Imported (Denmark))
0402020L0BBAHAC
|
Modecate | Fluphenazine decanoate | Central Nervous System | No data available |
|
Modecate 25mg/1ml inj ampoules (Imported (Germany))
0402020L0BBAIAC
|
Modecate | Fluphenazine decanoate | Central Nervous System | No data available |
|
Modecate 25mg/1ml solution for injection pre-filled syringes
0402020L0BBADAG
|
Modecate | Fluphenazine decanoate | Central Nervous System | No data available |
|
Modecate 50mg/2ml solution for injection ampoules
0402020L0BBACAD
|
Modecate | Fluphenazine decanoate | Central Nervous System | No data available |
|
Modecate 50mg/2ml solution for injection pre-filled syringes
0402020L0BBAEAH
|
Modecate | Fluphenazine decanoate | Central Nervous System | No data available |
|
Modecate Concentrate 100mg/1ml inj amp (Imported (Germany))
0402020L0BBAJAF
|
Modecate | Fluphenazine decanoate | Central Nervous System | No data available |
|
Modecate Concentrate 50mg/0.5ml inj ampoules
0402020L0BBAFAB
|
Modecate | Fluphenazine decanoate | Central Nervous System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.